CSii Vision and Highlights

CSii completed the development of IGAR, a propriety robotic platform with image guidance and automation capabilities and software architecture that supports tele-operation.

IGAR provides an unrivaled level of physical accuracy and precisionin the biopsy and treatment of breast disease.  CSii is working to complement this with a set of advanced decision support tools in aid of clinicians or operators navigating the diagnostic and interventional process.

CSii partnered with MDA to initiate a start up to commercialize the technology that has licensed the IP to commercialize IGAR Breast in North American and international markets. CSii will partner with IBM to adopt the Watson platform to layer these capabilities over time into a fully autonomous product solution.

The CSii – MDA start-up, Insight Medbotics, jointly owned by CSii and MDA, will create over 100 high tech jobs in Southern Ontario and Canada, attract bright and talented engineers and physicians, and facilitate the training of scores of highly qualified individuals. 

In addition to the partnership of the co-founders, Insight Medbotics is working to establish partnerships in distribution (GE Healthcare, Stryker, Hologic, others) as well as therapeutic device manufacturers (Sanaurs and others).  Insight will be addressing a global market and will be exporting via subsidiaries and partnerships to US and European markets.

CSii has also received the support of the Canadian Space Agency (CSA) through the Build in Canada Program established by the Government of Canada.  CSii is working with MDA to develop telerobotic capabilities for IGAR-Breast and additional IGAR platforms in development with the goal of increasing access to healthcare for Canadians living in remote areas of the country and for use in future space missions.